护士远程支持对糖尿病患者在专科与基层医疗间过渡的影响:随机对照试验研究方案
该研究为随机对照试验方案,纳入血糖控制稳定(糖化血红蛋白<8%)且符合从专科转至基层条件的2型糖尿病患者,随机分为护士定期电话支持联合基层随访组与单纯基层常规随访组。主要结局为一年随访时两组糖化血红蛋白所评估的血糖控制比较;试验注册号NCT02768480,注册日期2016年4月29日。
要点
- 纳入标准为糖化血红蛋白<8%的稳定2型糖尿病患者,符合从专科转至基层条件。
- 干预组接受每三个月一次、持续一年的护士电话支持,并可拨打免费电话咨询。
- 主要结局为一年随访时两组糖化血红蛋白所评估的血糖控制比较。
核心结论
- 研究计划评估基于电话的干预对由基层团队随访的2型糖尿病患者血糖控制的有效性。
- 远程医疗可能成为2型糖尿病管理的重要辅助手段,改善患者教育和对疾病的认知,并可能通过减轻专科医疗负担、支持基层医疗的管理职责来帮助医疗系统。
研究设计与样本
- 研究设计为随机对照试验(RCT),方案已注册于Clinical Trials,注册号NCT02768480,注册日期2016年4月29日。
- 纳入标准为血糖控制稳定(糖化血红蛋白<8%)且被认为符合从专科转至基层条件的2型糖尿病患者。
- 排除标准包括未控制的缺血性心脏病、严重神经病变和IV/V期肾病。
- 入组患者随机分为两组:干预组接受护士定期电话支持的随访加基层医疗,对照组仅接受常规基层医疗。
- 干预组接受定期电话呼叫(每三个月一次,持续一年),并设有免费电话号码供患者就疾病管理问题致电咨询。
主要发现
- 主要结局指标为一年随访时两组间血糖控制的比较,以糖化血红蛋白评估。
关键数值与推荐
- 纳入标准:糖化血红蛋白<8%。
- 干预组电话呼叫频率:每三个月一次,持续一年。
- 主要结局评估时间点:一年随访。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: According to the Global Diabetes Plan, a unified health system with preventive and educational strategies is essential to proper diabetes care and primary settings should be the main site of care. In Brazil, there is limited access to outpatient hospital diabetes services, while primary-care diabetes support is underutilized. Telemedicine can be a useful adjunct to support discharge of stable patients with type 2 diabetes to the primary care setting. In this paper, we present a randomized controlled trial (RCT) protocol designed to evaluate the effects of telehealth support for stable type 2 diabetes patients discharged from hospital outpatient diabetes clinics. METHODS: We designed a RCT. Patients with stable type 2 diabetes (glycated hemoglobin < 8%) considered eligible for discharge from specialized to primary care will be included. Those with uncontrolled ischemic heart disease, severe neuropathy, and stage IV/V nephropathy will be excluded. Enrolled patients will be randomized into two groups: follow-up supported by periodic phone calls by a nurse (intervention group) plus primary care or routine primary care only (control group). The intervention group will receive regular telephone calls (every three months for one year) and will have a toll-free number to call in case of questions about disease management. The main outcome measure is a comparison of glycemic control between groups (assessed by glycated hemoglobin) at one-year follow-up. DISCUSSION: We plan to evaluate the effectiveness of a telephone-based intervention on glycemic control in patients with type 2 diabetes followed by primary care teams. Telemedicine can be an important adjunct in type 2 diabetes management, improving patient education and knowledge about the disease. Furthermore, it can help the healthcare system by alleviating overload in specialized care settings and supporting the stewardship role of primary care. TRIAL REGISTRATION: Clinical Trials, NCT02768480 . Registered on 29 April 2016.
引用
- Moreira AM, Marobin R, Rados DV, et al. Effects of nurse telesupport on transition between specialized and primary care in diabetic patients: study protocol for a randomized controlled trial. Trials. 2017. PMID: 28521796. doi:10.1186/s13063-017-1954-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。